Feb. 17, 2016 – In the face of global problems, such as Ebola outbreak, catastrophic pollution, or world hunger, you may have thought to yourself: “someone should do something about that.” According to Tom Schoenfeld, formerly of Madison-based Lucigen Corp., the biotechnology industry is that “someone” who can do “something.”
Register for Biotech and the Law Conference by March 15, Save $200
Biotech is becoming increasingly important to the American and global economies. Lawyers are central to this growth, providing a linking thread through government, industry, and university efforts to grow this sector. With its explosive growth in university research and technology transfer to business development, Wisconsin is a microcosm of what is going on nationally.
The Biotech and the Law Conference brings together the diverse voices of the global biotechnology industry – government, university, law, and business – to learn from each other and build a foundation for mutual success. It is the place to forge connections.
Attendees will have the opportunity to talk to preeminent national and international speakers and attendees about current issues in biotech, get hands-on experience through excursions and expositions, and network with colleagues. Continuing legal education credits are also available.
Visit www.biotechandthelaw.com.
And while it may seem like the sole province of highly credentialed scientists, the biotech industry, like any other industry, needs “someone” to draft contracts, enforce patents, and ultimately design laws that protect research and prevent abuse.
And the lawyer is that “someone.”
Recognizing that lawyers are central to the growth of the biotech industry, in Wisconsin and beyond, State Bar of Wisconsin PINNACLE® is hosting the inaugural 2016 Biotech and the Law Global Conference, May 5-7, at the Monona Terrace in Madison.
At this event, lawyers will learn about legal and other issues facing the biotech industry – alongside the scientists, investors, and business people who are in biotech.
Through local excursions, they can immerse themselves in the “science” behind biotechnology. And they can explore opportunities to help biotech be the “someone” who is doing “something” about the world’s biggest and most complex problems.
Business Opportunities: Midwest is the ‘Third Coast’ of Biotech
Attorneys should become more familiar with the growing opportunities that biotech brings to Wisconsin and much of the Midwest. These business prospects are available here and now, says Dr. Tom Tubon, a professor in the biotechnology department at Madison College and a speaker at the upcoming Biotech and the Law Conference.
“Wisconsin and the Midwest corridor, we’re considered the ‘third coast,’” says Tubon. “Biotech has traditionally been pretty heavy on the west and east coasts, but here in the Midwest, opportunities are continuing to grow.”
In fact, during the Great Recession, “where everyone was facing economic challenge, biotech kept on growing at a rate of about three-percent per year,” Tubon said. “In Wisconsin, what we’re looking at is continued growth, even in the face of recession.”
Nontraditional Startups
While biotech may be considered much like any industry when it comes to the need for business and patent lawyers, it does have some unique characteristics.
Learn More: How Biotech and Lawyers are Linked
“Inventions and Innovations: Lawyers Play Important Role in the Biotech Industry,” InsideTrack, Oct. 7, 2015
The biotechnology industry continues to grow, globally and in Wisconsin. Learn why lawyers are essential in helping biotechnology companies grow and prosper.
“Wisconsin Biotech: A New Frontier for Lawyers,” Wisconsin Lawyer, November 2015
Impressive dividends await lawyers who have the initiative, flexibility, and imagination to approach the world of biotechnology. There are many entry points, and you don’t have to be a scientist to participate.
“Lawyers: Essential to the Growth of Biotechnology – Find Out More at the 2016 Biotech and the Law Conference,” InsideTrack, Jan. 6, 2016
The legal profession is central to the growth of the biotech industry, and lawyers are needed. To bring together lawyers, scientists and leaders of the biotech field, the State Bar of Wisconsin PINNACLE is hosting the inaugural 2016 Biotech and the Law Global Conference and Expo in May.
“Wisconsin, Beer, and Biotechnology,” Wisconsin Lawyer, November 2015
The first-ever Biotech and the Law Global Conference and Expo, May 5-7, 2016, connects leaders in biotechnology – scientists, industry managers, and lawyers – to make strategic alliances for the future in the dynamic health care, environmental science, and agriculture sectors.
“Biotechnology is a little bit of a nontraditional industry in that many of the innovations start at a true startup level,” says attorney David Casimir of Casimir Jones S.C., an intellectual property law firm based in Middleton, Wis. “A university professor has an idea, they start a company that has one employee, or maybe two or three employees to begin with, and then if the technology ends up panning out, it grows and grows and grows and then typically either becomes a big company or gets acquired by a big company.”
Potential for Solving Our Greatest Problems
Business prospects aside, what’s truly exciting about biotech is its potential to impact the lives of everyday people. “These [are] really amazing emerging technologies,” says Tubon.
“We’re talking about additive manufacturing, cell-based printing, the world of stem cells and regenerative medicine itself, drug discovery and the FDA,” says Tubon. “All of these things have an impact on society and we have to as a society start thinking about how this impacts the way that we live.” Lawyers will play a critical role in that process.
“I think the most exciting part for me,” says Casimir, “is the problems that are solved by this industry are some of the greatest ones we have.”
Casimir says that major diseases like cancer, dementia, Alzheimer’s disease, depression – really complex things that day-to-day dramatically affect people’s lives – have been unsolvable for as long as humans have been around. “But we are at the cusp of solving all of these, and it’s coming from the biotechnology industry,” he said.